Novo Nordisk's (NOVOB DC) CFO says there is still very low penetration in the Chinese obesity drug market as competition has been intense
Novo Nordisk's CFO highlights the low market penetration for obesity drugs in China amidst fierce competition, which suggests potential challenges for future growth in that region.
US Labour Department says all agencies will fully resume to normal operations from the 4th of February 2026
Watches of Switzerland (WOSG LN) says Q3 and FY 2026 holiday trading continues strong H1 trends
Novo Nordisk's (NOVOB DC) CFO says there is still very low penetration in the Chinese obesity drug market as competition has been intense
German VDMA Engineering Association December orders comes at -5% Y/Y
EU HCOB Services PMI Final (Jan) 51.6 vs. Exp. 51.9 (Prev. 52.4)
Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.
- They are expecting a percentage decline in 2026 US sales in the teens.
The expectation of a significant decline in U.S. sales by 2026 indicates a cautious outlook that could weigh on investor sentiment and affect sector dynamics, especially if peers are also struggling. This situation merits close monitoring for its implications on market positioning and overall revenue forecasts.
Related headlines
- Newsquawk Daily European Equity Opening News - 11th September 20262 days ago
- Newsquawk Daily European Equity Opening News - 10th September 20263 days ago
- Newsquawk Daily European Equity Opening News - 9th September 20264 days ago
- Stellantis (STLAM IM/STLAP FP) plans to invest EUR 1bln+ to design and build a new van in France1 day ago
- Ipsen (IPN FP) CEO says that they are considering potential US manufacturing investment for plant to make neuroscience drugs2 days ago
- European Movers: Alstom (ALO FP) +1.7%, Airbus (AIR FP) +1.6%, UniCredit (UCG IM) +1%, Commerzbank (CBK GY) +0.6%, SAP (SAP GY) -1.6%2 days ago
- Additional European Equity News - 11th September 20262 days ago
- European Equity pre-Market Summary - 11th September 2026: European bourses rebound, with focus on the US CPI2 days ago
- Ryanair (RYA ID) CEO says that if oil prices remain higher into the next year, then he believes that there will be a "significant" uplift in airfares; have stopped hedging oil prices in recent weeks3 days ago
- European Movers: Fortum (FORTUM FH) +3%, Porsche AG (P911 GY) +1.4%, Novartis (NOVN SW) +0.8%, Associated British Foods (ABF LN) -10%3 days ago
- Additional European Equity News - 10th September 20263 days ago
- European Equity pre-Market Summary - 10th September 2026: European bourses set for a mildly firmer open; Porsche AG lifts guidance3 days ago
- Crystler (STLAM IM/STLAP FP) files to recall over 200k US vehicles4 days ago
- European Movers: Airbus (AIR FP) -1.3%, LVMH (MC FP) -1.3%, Orsted (ORSTED DC) -1.6%, Inditex (ITX SM) -3%, Burberry (BRBY LN) -3%4 days ago
- Additional European Equity News - 9th September 20264 days ago
- European Equity pre-Market Summary - 9th September 2026: European bourses are indicative of a slightly softer open; Inditex reports poor results4 days ago
- European Movers: Airbus (AIR FP) -0.7%, Schneider Electric (SU FP) -0.9%, Société Générale (GLE FP) -1.6%, Infineon (IFX GY) -1.9%, Novartis (NOVN SW) -9%, 5 days ago
- Additional European Equity News - 8th September 20265 days ago
- European Equity pre-Market Summary - 8th September 2026: Novartis does not meet Phase 3 primary endpoint; European equity futures indicative of a slightly lower open, as energy picks up5 days ago
- Newsquawk Daily European Equity Opening News - 8th September 20265 days ago
The whole workspace, free to try.
Try it free